Status:
RECRUITING
Texture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel Diseases
Lead Sponsor:
University of Ulm
Conditions:
Inflammatory Bowel Diseases
Colitis, Ulcerative
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the context of the COLORIZE study, it is being tested whether the endoscopic light mode Texture and Color Enhancement Imaging (TXI) is non-inferior to the standard White Light Endoscopy (WLE) in as...
Detailed Description
In order to make meaningful therapy decisions for patients with IBD, regular assessment of the extent of intestinal inflammation is necessary. This is particularly true for patients with Crohn\'s ...
Eligibility Criteria
Inclusion
- Histologically confirmed inflammatory bowel disease (ulcerative colitis or Crohn\'s disease)
- Age ≥ 18 years
Exclusion
- Post (procto-) colectomy
- Endoscopically impassable stenosis in the left hemi-colon
- ASA status \> 2 points
- BBPS \< 6 points (or \< 2 points per segment)
- Severe coagulation disorder
- Pregnancy, lactation
Key Trial Info
Start Date :
May 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06892990
Start Date
May 8 2024
End Date
September 1 2025
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ulm University Hospital
Ulm, Baden-Wurttemberg, Germany, 89081